|
Commitments and Contingencies (Details)
In Millions, unless otherwise specified |
3 Months Ended | 0 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2014
item
|
Feb. 01, 2013
|
Mar. 31, 2015
|
Jan. 31, 2013
|
|
| Commitments and Contingencies [Line Items] | ||||
| Loss Contingency, New Claims Filed, Number | 4us-gaap_LossContingencyNewClaimsFiledNumber | |||
| 2011 Incentive Plan [Member] | ||||
| Commitments and Contingencies [Line Items] | ||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
35.0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized / us-gaap_PlanNameAxis = lng_A2011IncentivePlanMember |
35.0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized / us-gaap_PlanNameAxis = lng_A2011IncentivePlanMember |
10.0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized / us-gaap_PlanNameAxis = lng_A2011IncentivePlanMember |
|
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized |
25us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized / us-gaap_PlanNameAxis = lng_A2011IncentivePlanMember |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The total number of new claims filed pertaining to a loss contingency during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of additional shares authorized for issuance under an established share-based compensation plan. No definition available.
|
| X | ||||||||||
|
- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|